Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Automated Detection of Celiac Disease on Duodenal Biopsy Slides: A Deep Learning Approach.

Wei JW, Wei JW, Jackson CR, Ren B, Suriawinata AA, Hassanpour S.

J Pathol Inform. 2019 Mar 8;10:7. doi: 10.4103/jpi.jpi_87_18. eCollection 2019.

2.

Automating the Paris System for urine cytopathology-A hybrid deep-learning and morphometric approach.

Vaickus LJ, Suriawinata AA, Wei JW, Liu X.

Cancer Cytopathol. 2019 Feb;127(2):98-115. doi: 10.1002/cncy.22099. Epub 2019 Jan 31.

PMID:
30702803
3.

Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology.

Ren B, Liu X, Suriawinata AA.

Am J Pathol. 2019 Jan;189(1):9-21. doi: 10.1016/j.ajpath.2018.10.004. Review.

PMID:
30558727
4.

Mucosal inflammation in Candida esophagitis has distinctive features that may be helpful diagnostically.

Martin IW, Atkinson AE, Liu X, Suriawinata AA, Lefferts JA, Lisovsky M.

Mod Pathol. 2018 Nov;31(11):1653-1660. doi: 10.1038/s41379-018-0060-4. Epub 2018 Jun 19.

PMID:
29921901
5.

Short-term Preoperative Diet Decreases Bleeding After Partial Hepatectomy: Results From a Multi-institutional Randomized Controlled Trial.

Barth RJ Jr, Mills JB, Suriawinata AA, Putra J, Tosteson TD, Axelrod D, Freeman R, Whalen GF, LaFemina J, Tarczewski SM, Kinlaw WB.

Ann Surg. 2019 Jan;269(1):48-52. doi: 10.1097/SLA.0000000000002709.

PMID:
29489484
6.

Deep Learning for Classification of Colorectal Polyps on Whole-slide Images.

Korbar B, Olofson AM, Miraflor AP, Nicka CM, Suriawinata MA, Torresani L, Suriawinata AA, Hassanpour S.

J Pathol Inform. 2017 Jul 25;8:30. doi: 10.4103/jpi.jpi_34_17. eCollection 2017.

7.

Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.

Andrew AS, Baron JA, Butterly LF, Suriawinata AA, Tsongalis GJ, Robinson CM, Amos CI.

Int J Mol Sci. 2017 Mar 2;18(3). pii: E535. doi: 10.3390/ijms18030535.

8.

Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms.

Hedayat AA, Lisovsky M, Suriawinata AA, Longnecker DS.

Pancreatology. 2017 Mar - Apr;17(2):263-266. doi: 10.1016/j.pan.2017.02.004. Epub 2017 Feb 8.

PMID:
28215485
9.

A case of S-100 negative melanoma: A diagnostic pitfall in the workup of a poorly differentiated metastatic tumor of unknown origin.

Biernacka A, Linos KD, DeLong PA, Suriawinata AA, Padmanabhan V, Liu X.

Cytojournal. 2016 Sep 20;13:21. eCollection 2016.

10.

Number of Lymph Nodes in Primary Nodal Basin and a "Second Look" Protocol as Quality Indicators for Optimal Nodal Staging of Colon Cancer.

Lisovsky M, Schutz SN, Drage MG, Liu X, Suriawinata AA, Srivastava A.

Arch Pathol Lab Med. 2017 Jan;141(1):125-130. doi: 10.5858/arpa.2015-0401-OA. Epub 2016 Sep 28.

PMID:
27681330
11.

The genomic profile of pancreatic adenocarcinoma and its relationship to metastatic disease.

Pierce KJ, de Abreu FB, Peterson JD, Suriawinata AA, Tsongalis GJ, Liu X.

Exp Mol Pathol. 2016 Oct;101(2):172-175. doi: 10.1016/j.yexmp.2016.07.011. Epub 2016 Aug 3. No abstract available.

PMID:
27498048
12.

PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.

Qian DC, Xiao X, Byun J, Suriawinata AA, Her SC, Amos CI, Barth RJ Jr.

Clin Cancer Res. 2017 Jan 15;23(2):399-406. doi: 10.1158/1078-0432.CCR-16-0623. Epub 2016 Jul 19.

13.

The utility of repeat liver biopsy in autoimmune hepatitis: a series of 20 consecutive cases.

Putra J, Toor A, Suriawinata AA.

Pathology. 2016 Aug;48(5):449-53. doi: 10.1016/j.pathol.2016.05.001. Epub 2016 Jun 13.

PMID:
27306577
14.

Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases.

Lo RC, Suriawinata AA, Rubin BP.

Clin Mol Hepatol. 2016 Mar;22(1):188-91. doi: 10.3350/cmh.2016.22.1.188.

15.

Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.

Allaway RJ, Fischer DA, de Abreu FB, Gardner TB, Gordon SR, Barth RJ, Colacchio TA, Wood M, Kacsoh BZ, Bouley SJ, Cui J, Hamilton J, Choi JA, Lange JT, Peterson JD, Padmanabhan V, Tomlinson CR, Tsongalis GJ, Suriawinata AA, Greene CS, Sanchez Y, Smith KD.

Oncotarget. 2016 Mar 29;7(13):17087-102. doi: 10.18632/oncotarget.7718.

16.

Clinical Significance of Loss of ARID1A Expression in Colorectal and Small Intestinal Carcinoma.

Putra J, Suriawinata AA.

Clin Transl Gastroenterol. 2015 Dec 17;6:e131. doi: 10.1038/ctg.2015.64. No abstract available.

17.

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

Tafe LJ, Gorlov IP, de Abreu FB, Lefferts JA, Liu X, Pettus JR, Marotti JD, Bloch KJ, Memoli VA, Suriawinata AA, Dragnev KH, Fadul CE, Schwartz GN, Morgan CR, Holderness BM, Peterson JD, Tsongalis GJ, Miller TW, Chamberlin MD.

Oncologist. 2015 Sep;20(9):1011-8. doi: 10.1634/theoncologist.2015-0097. Epub 2015 Jul 23.

18.

Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.

Putra J, de Abreu FB, Peterson JD, Pipas JM, Mody K, Amos CI, Tsongalis GJ, Suriawinata AA.

Exp Mol Pathol. 2015 Oct;99(2):240-4. doi: 10.1016/j.yexmp.2015.07.005. Epub 2015 Jul 17.

19.

Multiple liver lesions in a patient with Budd-Chiari syndrome secondary to polycythemia vera.

Putra J, Toor A, Noce TA, Thung SN, Suriawinata AA, Lisovsky M.

Ann Hepatol. 2015 Jul-Aug;14(4):547-9.

20.

Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.

Liu J, Yuan Y, Chen W, Putra J, Suriawinata AA, Schenk AD, Miller HE, Guleria I, Barth RJ, Huang YH, Wang L.

Proc Natl Acad Sci U S A. 2015 May 26;112(21):6682-7. doi: 10.1073/pnas.1420370112. Epub 2015 May 11.

21.

Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis.

Glass LM, Dickson RC, Anderson JC, Suriawinata AA, Putra J, Berk BS, Toor A.

Dig Dis Sci. 2015 Apr;60(4):1024-30. doi: 10.1007/s10620-014-3380-3. Epub 2014 Oct 30.

PMID:
25354830
22.

Adenovirus hepatitis presenting as tumoral lesions in an immunocompromised patient.

Putra J, Suriawinata AA.

Ann Hepatol. 2014 Nov-Dec;13(6):827-9.

23.

Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.

Wang L, Le Mercier I, Putra J, Chen W, Liu J, Schenk AD, Nowak EC, Suriawinata AA, Li J, Noelle RJ.

Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14846-51. doi: 10.1073/pnas.1407447111. Epub 2014 Sep 29.

24.

The microbiota regulates susceptibility to Fas-mediated acute hepatic injury.

Celaj S, Gleeson MW, Deng J, O'Toole GA, Hampton TH, Toft MF, Morrison HG, Sogin ML, Putra J, Suriawinata AA, Gorham JD.

Lab Invest. 2014 Sep;94(9):938-49. doi: 10.1038/labinvest.2014.93. Epub 2014 Jul 28.

25.

The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus.

Gardner TB, Hessami N, Smith KD, Ripple GH, Barth RJ, Klibansky DA, Colacchio TA, Zaki B, Tsapakos MJ, Suriawinata AA, Putra J, Tsongalis GJ, Mody K, Gordon SR, Pipas JM.

Pancreas. 2014 Oct;43(7):1018-21. doi: 10.1097/MPA.0000000000000162.

PMID:
25000339
26.

Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.

Liu X, Mody K, de Abreu FB, Pipas JM, Peterson JD, Gallagher TL, Suriawinata AA, Ripple GH, Hourdequin KC, Smith KD, Barth RJ Jr, Colacchio TA, Tsapakos MJ, Zaki BI, Gardner TB, Gordon SR, Amos CI, Wells WA, Tsongalis GJ.

Clin Chem. 2014 Jul;60(7):1004-11. doi: 10.1373/clinchem.2014.225565. Epub 2014 May 12.

27.

VISTA is an immune checkpoint molecule for human T cells.

Lines JL, Pantazi E, Mak J, Sempere LF, Wang L, O'Connell S, Ceeraz S, Suriawinata AA, Yan S, Ernstoff MS, Noelle R.

Cancer Res. 2014 Apr 1;74(7):1924-32. doi: 10.1158/0008-5472.CAN-13-1504. Erratum in: Cancer Res. 2014 Jun 1;74(11):3195.

28.

A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.

Brand RE, Adai AT, Centeno BA, Lee LS, Rateb G, Vignesh S, Menard C, Wiechowska-Kozłowska A, Bołdys H, Hartleb M, Sanders MK, Munding JB, Tannapfel A, Hahn SA, Stefańczyk L, Tsongalis GJ, Whitcomb DC, Conwell DL, Morisset JA, Gardner TB, Gordon SR, Suriawinata AA, Lloyd MB, Wylie D, Labourier E, Andruss BF, Szafranska-Schwarzbach AE.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1717-23. doi: 10.1016/j.cgh.2014.02.038. Epub 2014 Mar 21.

PMID:
24662333
29.

Chromosomal instability portends superior response of rectal adenocarcinoma to chemoradiation therapy.

Zaki BI, Suriawinata AA, Eastman AR, Garner KM, Bakhoum SF.

Cancer. 2014 Jun 1;120(11):1733-42. doi: 10.1002/cncr.28656. Epub 2014 Mar 6.

30.

Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant therapy and pancreaticoduodenectomy.

Gowarty MA, Zaki BI, Tsapakos MJ, Gordon SR, Suriawinata AA, Tsongalis GJ, Sutton JE, Pipas JM.

Gastrointest Cancer Res. 2013 Jul;6(4):118-9. No abstract available.

31.

Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults.

Gardner TB, Glass LM, Smith KD, Ripple GH, Barth RJ, Klibansky DA, Colacchio TA, Tsapakos MJ, Suriawinata AA, Tsongalis GJ, Pipas JM, Gordon SR.

Am J Gastroenterol. 2013 Oct;108(10):1546-50. doi: 10.1038/ajg.2013.103.

32.

MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.

Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth RJ Jr, Suriawinata AA, Tsongalis GJ.

Cancer Genet. 2013 Jun;206(6):217-21. doi: 10.1016/j.cancergen.2013.05.020. Epub 2013 Aug 9.

PMID:
23933230
33.

Short-term preoperative diet modification reduces steatosis and blood loss in patients undergoing liver resection.

Reeves JG, Suriawinata AA, Ng DP, Holubar SD, Mills JB, Barth RJ Jr.

Surgery. 2013 Nov;154(5):1031-7. doi: 10.1016/j.surg.2013.04.012. Epub 2013 Jun 27.

PMID:
23809869
34.

The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition.

Stan RV, Tse D, Deharvengt SJ, Smits NC, Xu Y, Luciano MR, McGarry CL, Buitendijk M, Nemani KV, Elgueta R, Kobayashi T, Shipman SL, Moodie KL, Daghlian CP, Ernst PA, Lee HK, Suriawinata AA, Schned AR, Longnecker DS, Fiering SN, Noelle RJ, Gimi B, Shworak NW, Carrière C.

Dev Cell. 2012 Dec 11;23(6):1203-18. doi: 10.1016/j.devcel.2012.11.003.

35.

Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.

Guillem JG, Ruby JA, Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM.

Ann Surg. 2013 Aug;258(2):289-95. doi: 10.1097/SLA.0b013e318277b625.

PMID:
23187748
36.

Invasive mucinous cystic neoplasms of the pancreas.

Baker ML, Seeley ES, Pai R, Suriawinata AA, Mino-Kenudson M, Zamboni G, Klöppel G, Longnecker DS.

Exp Mol Pathol. 2012 Dec;93(3):345-9. doi: 10.1016/j.yexmp.2012.07.005. Epub 2012 Aug 10.

PMID:
22902940
37.

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.

Pipas JM, Zaki BI, McGowan MM, Tsapakos MJ, Ripple GH, Suriawinata AA, Tsongalis GJ, Colacchio TA, Gordon SR, Sutton JE, Srivastava A, Smith KD, Gardner TB, Korc M, Davis TH, Preis M, Tarczewski SM, Mackenzie TA, Barth RJ Jr.

Ann Oncol. 2012 Nov;23(11):2820-7. doi: 10.1093/annonc/mds109. Epub 2012 May 9.

38.

Endoscopic vs. laparoscopic gastrojejunostomy for duodenal obstruction: a randomized study in a porcine model.

von Renteln D, Vassiliou MC, McKenna D, Suriawinata AA, Swain CP, Rothstein RI.

Endoscopy. 2012 Feb;44(2):161-8. doi: 10.1055/s-0031-1291447. Epub 2011 Nov 22.

PMID:
22109650
39.

KRAS detection in colonic tumors by DNA extraction from FTA paper: the molecular touch-prep.

Petras ML, Lefferts JA, Ward BP, Suriawinata AA, Tsongalis GJ.

Diagn Mol Pathol. 2011 Dec;20(4):189-93. doi: 10.1097/PDM.0b013e318211d554.

PMID:
22089345
40.

Correlation of polypoid colorectal adenocarcinoma with pre-existing adenomatous polyps and KRAS mutation.

Chen H, Lefferts JA, Schwab MC, Suriawinata AA, Tsongalis GJ.

Cancer Genet. 2011 May;204(5):245-51. doi: 10.1016/j.cancergen.2011.04.002.

PMID:
21665177
41.

Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma.

Gardner TB, Barth RJ, Zaki BI, Boulay BR, McGowan MM, Sutton JE, Ripple GH, Colacchio TA, Smith KD, Byock IR, Call M, Suriawinata AA, Tsapakos MJ, Mills JB, Srivastava A, Stannard M, Lisovsky M, Gordon SR, Pipas JM.

J Oncol Pract. 2010 Nov;6(6):288-92. doi: 10.1200/JOP.2010.000041.

42.

Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.

Sempere LF, Preis M, Yezefski T, Ouyang H, Suriawinata AA, Silahtaroglu A, Conejo-Garcia JR, Kauppinen S, Wells W, Korc M.

Clin Cancer Res. 2010 Aug 15;16(16):4246-55. doi: 10.1158/1078-0432.CCR-10-1152. Epub 2010 Aug 3.

43.

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani J.

Clin Chem. 2010 Jul;56(7):1107-18. doi: 10.1373/clinchem.2010.144709. Epub 2010 Apr 29.

44.

KRAS mutation detection: a new look at an old gene.

Lefferts JA, Tsongalis GJ, Suriawinata AA, Funkhouser WK, Ladanyi M, Nowak JA, Pipas JM.

Clin Chem. 2010 May;56(5):698-701. doi: 10.1373/clinchem.2009.138735. Epub 2010 Mar 5. No abstract available.

45.

Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.

Dhall D, Suriawinata AA, Tang LH, Shia J, Klimstra DS.

Hum Pathol. 2010 May;41(5):643-52. doi: 10.1016/j.humpath.2009.10.019. Epub 2010 Feb 9.

PMID:
20149413
46.

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.

du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.

Clin Chem. 2010 Apr;56(4):603-12. doi: 10.1373/clinchem.2009.137364. Epub 2010 Jan 21.

47.

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD, Pipas JM.

Clin Colorectal Cancer. 2009 Apr;8(2):100-5.

48.

Isolated asymptomatic ileitis does not progress to overt Crohn disease on long-term follow-up despite features of chronicity in ileal biopsies.

Courville EL, Siegel CA, Vay T, Wilcox AR, Suriawinata AA, Srivastava A.

Am J Surg Pathol. 2009 Sep;33(9):1341-7. doi: 10.1097/PAS.0b013e3181ad25b6.

PMID:
19606015
49.

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD, Pipas JM.

Clin Colorectal Cancer. 2009 Mar;8(2):100-5.

PMID:
19423503
50.

Neuroma of the bile duct: a late complication after cholecystectomy.

Paquette IM, Suriawinata AA, Ornvold K, Gardner TB, Axelrod DA.

J Gastrointest Surg. 2009 Aug;13(8):1517-9. doi: 10.1007/s11605-009-0814-x. Epub 2009 Jan 29.

PMID:
19184244

Supplemental Content

Loading ...
Support Center